212 related articles for article (PubMed ID: 20589692)
1. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators.
Schmajuk G; Yelin E; Chakravarty E; Nelson LM; Panopolis P; Yazdany J
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):993-1001. PubMed ID: 20589692
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.
Demas KL; Keenan BT; Solomon DH; Yazdany J; Costenbader KH
Semin Arthritis Rheum; 2010 Dec; 40(3):193-200. PubMed ID: 20378155
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
[TBL] [Abstract][Full Text] [Related]
4. Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.
Sreedharan S; Li N; Littlejohn G; Buchanan R; Nikpour M; Morand E; Hoi A; Golder V
Arthritis Res Ther; 2022 Jun; 24(1):150. PubMed ID: 35733186
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis in systemic lupus erythematosus: prevention and treatment.
Sen D; Keen RW
Lupus; 2001; 10(3):227-32. PubMed ID: 11315358
[TBL] [Abstract][Full Text] [Related]
7. [BONE MINERAL DENSITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS--OUR RESULTS].
Gracanin AG; Marković I; Loncarević J; Golob M; Morović-Vergles J
Reumatizam; 2015; 62(2):16-21. PubMed ID: 26882799
[TBL] [Abstract][Full Text] [Related]
8. Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus.
Ko D; Forrest N; Mai Q; Pawlowski A; Balsley K; Chung A; Ramsey-Goldman R; Walunas TL
Lupus; 2022 Oct; 31(12):1516-1522. PubMed ID: 35861184
[TBL] [Abstract][Full Text] [Related]
9. Fracture risk in systemic lupus erythematosus patients over 28 years.
Garelick D; Pinto SM; Farinha F; Pires T; Khan E; Isenberg D
Rheumatology (Oxford); 2021 Jun; 60(6):2765-2772. PubMed ID: 33221918
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation.
Caetano M; Terreri MT; Ortiz T; Pinheiro M; Souza F; Sarni R
Clin Rheumatol; 2015 Dec; 34(12):2065-70. PubMed ID: 26227163
[TBL] [Abstract][Full Text] [Related]
11. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Chavatza K; Kostopoulou M; Nikolopoulos D; Gioti O; Togia K; Andreoli L; Aringer M; Boletis J; Doria A; Houssiau FA; Jayne D; Mosca M; Svenungsson E; Tincani A; Bertsias G; Fanouriakis A; Boumpas DT
Ann Rheum Dis; 2021 Sep; 80(9):1175-1182. PubMed ID: 34162597
[TBL] [Abstract][Full Text] [Related]
12. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.
Boonen S; Vanderschueren D; Haentjens P; Lips P
J Intern Med; 2006 Jun; 259(6):539-52. PubMed ID: 16704554
[TBL] [Abstract][Full Text] [Related]
13. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al.
Praprotnik S; Tomsic M
Arthritis Rheum; 2007 Dec; 56(12):4228; author reply 4228-9. PubMed ID: 18050257
[No Abstract] [Full Text] [Related]
15. Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): A systematic review.
Salman-Monte TC; Torrente-Segarra V; Vega-Vidal AL; Corzo P; Castro-Dominguez F; Ojeda F; Carbonell-Abelló J
Autoimmun Rev; 2017 Nov; 16(11):1155-1159. PubMed ID: 28899800
[TBL] [Abstract][Full Text] [Related]
16. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
[TBL] [Abstract][Full Text] [Related]
17. Steroid-induced osteoporosis in systemic lupus erythematosus.
Cunnane G; Lane NE
Rheum Dis Clin North Am; 2000 May; 26(2):311-29, vi-vii. PubMed ID: 10768214
[TBL] [Abstract][Full Text] [Related]
18. [The effect of long-term low dose prednisone on bone mineral density in patients with systemic lupus erythematosus].
Wang G; Li XP; Li XM; Wang GS; Tao JH; Ma Y
Zhonghua Nei Ke Za Zhi; 2017 Mar; 56(3):179-183. PubMed ID: 28253597
[No Abstract] [Full Text] [Related]
19. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
Schmajuk G; Yazdany J; Trupin L; Yelin E
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):386-92. PubMed ID: 20391485
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density.
Pineau CA; Urowitz MB; Fortin PJ; Ibanez D; Gladman DD
Lupus; 2004; 13(6):436-41. PubMed ID: 15303570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
